Sergio
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Hospital Ramón y Cajal
Madrid, EspañaPublications in collaboration with researchers from Hospital Ramón y Cajal (4)
2023
-
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
Frontiers in Immunology, Vol. 14
2007
-
Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients
Human Mutation, Vol. 28, Núm. 6, pp. 613-621
2005
-
Brief report: Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma
Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 4, pp. 2127-2130
2002
-
Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma
European Journal of Human Genetics, Vol. 10, Núm. 8, pp. 457-461